The effect of metformin on clinically relevant outcomes in 3,144 IPF patients from the EMPIRE registry
D. Jovanovic (Beograd, Republic of Serbia), M. Šterclová (Prague, Czech Republic), N. Mogulkoc (Izmir, Turkey), K. Lewandowsk (Warsaw, Poland), V. Müller (Budapest, Hungary), M. Hájková (Bratislava, Slovakia), M. Kramer (Petah Tikva, Israel), J. Tekavec-Trkanjec (Zagreb, Croatia), M. Studnicka (Salzburg, Austria), N. Stoeva (Sofia, Bulgaria), B. Jovovska Kaeva (Skopje), S. Littnerová (Brno, Czech Republic), M. Roksandic Milenkovic (Beograd, Republic of Serbia), M. Vasakova (Prague, Czech Republic)
Source: Virtual Congress 2020 – What is hot in idiopathic pulmonary fibrosis?
Session: What is hot in idiopathic pulmonary fibrosis?
Session type: E-poster session
Disease area: Interstitial lung diseases
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Related content which might interest you: